1. Home
  2. HITI vs BIOA Comparison

HITI vs BIOA Comparison

Compare HITI & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo High Tide Inc.

HITI

High Tide Inc.

HOLD

Current Price

$2.66

Market Cap

220.6M

Sector

N/A

ML Signal

HOLD

Logo BioAge Labs Inc.

BIOA

BioAge Labs Inc.

HOLD

Current Price

$5.47

Market Cap

255.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HITI
BIOA
Founded
2009
2015
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
220.6M
255.6M
IPO Year
2021
2024

Fundamental Metrics

Financial Performance
Metric
HITI
BIOA
Price
$2.66
$5.47
Analyst Decision
Strong Buy
Buy
Analyst Count
7
10
Target Price
$4.67
★ $32.56
AVG Volume (30 Days)
530.7K
★ 830.4K
Earning Date
09-14-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 66.21
EPS
★ N/A
N/A
Revenue
N/A
★ $8,995,000.00
Revenue This Year
$27.52
N/A
Revenue Next Year
$10.52
$97.72
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.02
$4.81
52 Week High
$3.50
$25.96

Technical Indicators

Market Signals
Indicator
HITI
BIOA
Relative Strength Index (RSI) 51.52 31.30
Support Level $2.47 N/A
Resistance Level $2.73 $8.53
Average True Range (ATR) 0.09 0.37
MACD -0.01 0.10
Stochastic Oscillator 50.91 35.92

Price Performance

Historical Comparison
HITI
BIOA

About HITI High Tide Inc.

High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, and others. The company's reportable operating segments are: Bricks and mortar, which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada, followed by the United States of America, and other international markets.

About BIOA BioAge Labs Inc.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

Share on Social Networks: